| |
| |
|
| Insider
Information: |
Fenton Dennis M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
84,394 |
|
|
Indirect Shares
|
118,518 |
|
|
| Direct
Value |
$2,039,341 |
|
|
|
Indirect Value
|
$36,247,545 |
|
|
| Total
Shares |
202,912 |
|
|
| Total
Value |
$38,286,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amgen Inc |
AMGN |
Executive V.P., Operat... |
2007-06-04 |
6,668 |
2007-06-04 |
118,518 |
Premium* |
|
|
Genzyme Corp |
GENZ |
Director |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2016-07-05 |
0 |
2016-07-05 |
0 |
Premium* |
|
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
75,000 |
2012-01-03 |
0 |
Premium* |
|
|
Kythera Biopharmaceuticals Inc |
KYTH |
Director |
2012-10-16 |
1,476 |
2015-10-01 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2016-06-17 |
0 |
Premium* |
|
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
Director |
2017-09-18 |
1,250 |
2017-09-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GENZ |
Genzyme Corp |
Director |
– • – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
2,375 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2014-05-27 |
4 |
B |
$4.02 |
$12,046 |
D/D |
3,000 |
13,000 |
2.39 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2017-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
officerTitle |
• – – |
2005-12-06 |
4 |
D |
$79.78 |
$243,249 |
D/D |
(3,049) |
16,951 |
|
- |
|
| AMGN |
Amgen Inc |
Executive V.P., Operations |
• – – |
2006-12-06 |
4 |
D |
$69.89 |
$213,095 |
D/D |
(3,049) |
6,668 |
0 |
- |
|
| AMGN |
Amgen Inc |
Ex. VP Ops & Corp. Compliance |
• – – |
2004-07-27 |
4 |
OE |
$30.44 |
$100,033 |
D/D |
3,286 |
3,286 |
|
- |
|
| AMGN |
Amgen Inc |
Ex. VP Ops & Corp. Compliance |
• – – |
2004-07-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,286 |
0 |
|
- |
|
| AMGN |
Amgen Inc |
Ex. VP Ops & Corp. Compliance |
• – – |
2004-07-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,286 |
165,881 |
|
- |
|
| KYTH |
Kythera Biopharmaceutical... |
Director |
– • – |
2015-10-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,348) |
0 |
0 |
- |
|
| AMGN |
Amgen Inc |
Executive V.P., Operations |
• – – |
2005-12-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,617 |
13,334 |
0 |
- |
|
| AMGN |
Amgen Inc |
Executive V.P., Operations |
• – – |
2005-12-06 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,617 |
84,883 |
0 |
- |
|
| AMGN |
Amgen Inc |
Executive V.P., Operations |
• – – |
2006-12-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,617 |
9,717 |
0 |
- |
|
| AMGN |
Amgen Inc |
Executive V.P., Operations |
• – – |
2006-12-06 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,617 |
89,417 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,194 |
13,194 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2013-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2014-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2015-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
18,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2016-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
23,000 |
0 |
- |
|
| AMGN |
Amgen Inc |
Executive Vice President |
• – – |
2003-07-31 |
4 |
OE |
$16.38 |
$99,953 |
D/D |
6,104 |
6,104 |
|
- |
|
| AMGN |
Amgen Inc |
Executive Vice President |
• – – |
2003-07-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,104 |
0 |
|
- |
|
| AMGN |
Amgen Inc |
Executive Vice President |
• – – |
2003-07-31 |
4 |
GA |
$0.00 |
$0 |
D/D |
6,104 |
143,255 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,281 |
20,475 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$131,058 |
D/D |
(7,281) |
0 |
0 |
- |
|
102 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
